These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1831817)

  • 1. Stereoselective disposition of etodolac enantiomers in synovial fluid.
    Brocks DR; Jamali F; Russell AS
    J Clin Pharmacol; 1991 Aug; 31(8):741-6. PubMed ID: 1831817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantioselective pharmacokinetics of etodolac in the rat: tissue distribution, tissue binding, and in vitro metabolism.
    Brocks DR; Jamali F
    J Pharm Sci; 1991 Nov; 80(11):1058-61. PubMed ID: 1839997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etodolac clinical pharmacokinetics.
    Brocks DR; Jamali F
    Clin Pharmacokinet; 1994 Apr; 26(4):259-74. PubMed ID: 8013160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of etodolac enantiomers in the rat. Lack of pharmacokinetic interaction between enantiomers.
    Brocks DR; Jamali F
    Drug Metab Dispos; 1990; 18(4):471-5. PubMed ID: 1976070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritis.
    Kraml M; Hicks DR; McKean M; Panagides J; Furst D
    Clin Pharmacol Ther; 1988 May; 43(5):571-6. PubMed ID: 2966693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug-protein binding in human plasma.
    Jin YX; Tang YH; Zeng S
    J Pharm Biomed Anal; 2008 Apr; 46(5):953-8. PubMed ID: 18329215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a stereospecific high-performance liquid chromatography assay to a pharmacokinetic study of etodolac enantiomers in humans.
    Jamali F; Mehvar R; Lemko C; Eradiri O
    J Pharm Sci; 1988 Nov; 77(11):963-6. PubMed ID: 2976091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and synovial fluid concentrations of flurbiprofen enantiomers in horses: chiral inversion.
    Soraci AL; Tapia O; Garcia J
    J Vet Pharmacol Ther; 2005 Feb; 28(1):65-70. PubMed ID: 15720517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective disposition of ibuprofen enantiomers in synovial fluid.
    Day RO; Williams KM; Graham GG; Lee EJ; Knihinicki RD; Champion GD
    Clin Pharmacol Ther; 1988 May; 43(5):480-7. PubMed ID: 3365913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein binding and stereoselectivity of nonsteroidal anti-inflammatory drugs.
    Lapicque F; Muller N; Payan E; Dubois N; Netter P
    Clin Pharmacokinet; 1993 Aug; 25(2):115-23. PubMed ID: 8403735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stereoselective pharmacokinetics of etodolac in young and elderly subjects, and after cholecystectomy.
    Brocks DR; Jamali F; Russell AS; Skeith KJ
    J Clin Pharmacol; 1992 Nov; 32(11):982-9. PubMed ID: 1474171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin binding sites for etodolac enantiomers.
    Mignot I; Presle N; Lapicque F; Monot C; Dropsy R; Netter P
    Chirality; 1996; 8(3):271-80. PubMed ID: 8777148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective binding of etodolac to human serum albumin.
    Muller N; Lapicque F; Monot C; Payan E; Dropsy R; Netter P
    Chirality; 1992; 4(4):240-6. PubMed ID: 1389961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereospecific pharmacokinetics of free and protein-bound ketoprofen in serum and synovial fluid of horses after intravenous and intramuscular administration.
    Brink P; DeGraves F; Ravis WR; Johansen D; Campbell JD; Duran SH
    Am J Vet Res; 1998 Jun; 59(6):739-43. PubMed ID: 9622744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselective analysis of etodolac in human plasma by LC-MS/MS: Application to clinical pharmacokinetics.
    de Miranda Silva C; Rocha A; Tozatto E; da Silva LM; Donadi EA; Lanchote VL
    J Pharm Biomed Anal; 2016 Feb; 120():120-6. PubMed ID: 26723001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.
    Day RO; Williams KM; Graham S; Handel M
    Arthritis Rheum; 1991 Jun; 34(6):751-60. PubMed ID: 2053921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations.
    Day RO; Francis H; Vial J; Geisslinger G; Williams KM
    J Rheumatol; 1995 Dec; 22(12):2295-303. PubMed ID: 8835565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio.
    Hinderling PH; Hartmann D; Crevoisier C; Moser U; Heizmann P
    Ther Drug Monit; 1988; 10(3):250-60. PubMed ID: 3262939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of tiaprofenic acid and its enantiomers.
    Davies NM
    Clin Pharmacokinet; 1996 Nov; 31(5):331-47. PubMed ID: 9118583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral bioequivalence: effect of absorption rate on racemic etodolac.
    Boni JR; Korth-Bradley JM; Richards LS; Chiang ST; Hicks DR; Benet LZ
    Clin Pharmacokinet; 2000 Dec; 39(6):459-69. PubMed ID: 11192477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.